PROVIDER PROFILE · NPI 1700825395

Peter Logalbo

Allergy/ ImmunologyWest Nyack, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$8K

Distinct drugs

Brand share

12.4%

Top prescribed drugs

Fluticasone Propionate38 claims

Montelukast Sodium36 claims

Fluticasone/Vilanterol12 claims

Ipratropium Bromide11 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

89.9

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$564

Payment records

By payment type

Food and Beverage$564

REFERRAL NETWORK

Where Peter Logalbo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Marc Levine Otolaryngology · West Nyack, NY	31	103
Edward Rhee Otolaryngology · West Nyack, NY	18	35
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	16	46
MONTEFIORE NYACK HOSPITAL	14	29
GOOD SAMARITAN HOSPITAL OF SUFFERN	14	34
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	11	23

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history